In its first year since launch, weight loss telehealth platform Calibrate raised $100 million in capital funding from investors.
The series B funding round was co-led by Founders Fund and Tiger Global, both new investors, and had participation from Optum Ventures and existing investors. In addition to the funding, Brian Singerman, a partner at Founders Fund, will join Calibrate’s board of directors.
“We know that investing in preventative care works intuitively,” Calibrate’s founder and CEO Isabelle Kenyon said. “And so, year one at Calibrate was really about proving through outcomes and results that that makes sense, and that equation makes sense.”
This latest funding round means the company has raised a total of $127.6 million in cumulative funding.
Entering its second year of business, Calibrate looks to build out its enterprise business in addition to its already established consumer-facing business.
Calibrate focuses on metabolic health through its one-year, weight loss reset program that includes FDA-approved medication, doctor visits and app-based coaching and curriculum. With the weight loss goal of 10%, results have shown Calibrate members report an average annual body weight loss of 14%.
In the U.S., obesity prevalence was 42.4% in 2017-18, according to the Centers for Disease Control and Prevention.
Calibrate is the only business in the sector that is focused on biology, Kenyon said.